$2.32
-0.12-4.92%
Last update: Oct 23, 4:00 PM
CytomX Therapeutics Inc (CTMX) Stock Price, Quote, News & History
CTMXNASDAQ
CytomX Therapeutics stock jumps in premarket trading after Phase 1 data for Varseta-M showed tumor responses in colorectal cancer patients.
You can purchase shares of CytomX Therapeutics (NASDAQ:CTMX) through any online brokerage.
Other companies in CytomX Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
CytomX Therapeutics has a consensus price target of $10.60.
The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $2.32 last updated October 23, 2026 at 4:00 PM EDT.
There are no upcoming dividends for CytomX Therapeutics.
CytomX Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for CytomX Therapeutics.
CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics...
